MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma
FUTURE ONCOLOGY（2021）
关键词
checkpoint inhibitor,first-line therapy,gastric cancer,gastroesophageal adenocarcinoma,gastroesophageal junction cancer,HER2,immuno-oncology,I-O combination,LAG-3,PD-1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要